Orangelife Comercio e Industria Ltda.

Orangelife is a Brazilian diagnostics and medical device company focused on the manufacture and distribution of point-of-care infectious disease tests. The company operated from Rio de Janeiro and supplied ANVISA-approved rapid diagnostic products, including Brazil's first ANVISA-approved HIV self-test. It was a significant supplier of infectious disease testing products to Brazil's federal government and supported public health distribution channels. In November 2019, Chembio Diagnostics completed the acquisition of Orangelife and indicated the business would be renamed Chembio Diagnostics Brazil and operated as a wholly owned subsidiary. Based on available public information, Orangelife appears to have been a commercial-stage diagnostics business rather than a therapeutic biotech developer.